Published By: Syndicate Market Research
Antidiabetics Market Volume
Forecast and Value Chain Analysis
3422 SW 15 Street, Suit #8138,
Florida 33442, USA
Toll Free: 1-855-465-4651
Diabetes mellitus, commonly known as diabetes, is a group of metabolic diseases in
which blood sugar levels goes extremely high over a prolonged period. Antidiabetics are
the medicines developed to stabilize and control blood glucose (sugar) levels amongst
diabetes patient. Antidiabetic drugs are generally used to control diabetes. Insulin
pramlintide (Amylin), GLP-1 receptor agonists such as byetta and victoza are the
different types of antidiabetics drugs. The global antidiabetics market is driven by
increasing prevalence of diabetes mellitus.
Get Full report at http://www.syndicatemarketresearch.com/marketanalysis/antidiabetics-market.html
Increasing disposable income has been resulted into significant changes in lifestyle.
This in turn has been resulted into increasing incidences of disorders such as obesity
which may cause the diabetes. This is primarily triggered the demand for antidiabetics.
Additionally, advancement in pharmaceutical sector helps to drive the antidiabetics
market. However, high cost of insulin is expected to be a major restraint of
antidiabetics market. The market size and forecasts in terms of revenue (USD million)
for the period 2015 to 2020, considering 2014 as the base year, have been provided for
this segment of the report. The report also provides the compounded annual growth
rate (% CAGR) for the forecast period 2015 to 2020.
The report provides a comprehensive view on the antidiabetics; we have included a
detailed competitive scenario and product portfolio of key vendors. To understand the